Last Updated: February 16, 2024    

Featured Articles

National Black HIV/AIDS Awareness Day Toolkit 2024

AIDSVu | January 30, 2024

Estimating The Impact Of Out-Of-Pocket Cost Changes On Abandonment Of HIV Pre-Exposure Prophylaxis

Health Affairs | January 2024

Primary Care Clinicians Should Spearhead HIV Prevention

Medscape | September 19, 2023

USPSTF Gives 'A' Rating to All 3 Approved PrEP Medications, but Access Challenges Remain 

Infectious Disease Special Edition | September 1, 2023

New USPSTF Recommendations for HIV PrEP Should Expand Coverage of Affordable Drugs 

Everyday Health | August 25, 2023

Factors Associated With Long-Term Adherence to Daily HIV PrEP Among MSM 

Infectious Disease Advisor | July 7, 2023

Breakthrough HIV-1 infection in setting of cabotegravir for HIV pre-exposure prophylaxis

NIH | PubMed | July 4, 2023

AIDSVu Releases 2022 PrEP Use Data by Race/Ethnicity

AIDSVu | June 21, 2023

US Preventive Services Task Force recommends PrEP for HIV prevention

The Hill | December 14, 2022

10 Years After HIV PrEP Approval, Uptake Lowest Among Highest Risk Groups 

Contagion Live | August 2, 2022

AIDSVu Releases New Data Showing Significant Inequities in PrEP Use Among Black and Hispanic Americans

AIDSVu | july 29, 2022

HIV Prevention Drugs Work Great. Why Is Access So Inequitable?

Everyday Health | July 13, 2022


Courtesy of NATAP
Predicted uptake of novel HIV treatment options in the United States - (10/16/23)
Factors driving decisions in the use of HIV Pre-Exposure Prophylaxis: Data from a real-world study in the United States - (10/16/23)
Increase in New HIV Diagnoses Following Decrease in Use of Pre-exposure Prophylaxis (PrEP) During the COVID-19 Pandemic - (10/16/23)
The Real-World Impact of Pre-Exposure Prophylaxis (PrEP) Prescription Uptake and Dispensing Status on HIV Infection Risk in the US - (10/16/23)
Evaluating Pre-Exposure Prophylaxis Use in a Large Integrated Rural US Health System - (10/16/23)
Facilitators and Barriers to Engaging in PrEP and Gender Affirming Therapy for Black and Latina Transgender Women in South Florida - (10/16/23)
A Quality Improvement Initiative for HIV Prevention in Underserved Communities - (10/16/23)
Risk Factors, Risk Perception, and Long-Acting PrEP Awareness and Interest Among US Women: A National Survey - (10/16/23)
Exploring Cisgender Women's HIV Pre-Exposure Prophylaxis (PrEP) Needs and Preferences Across Settings: the Role of Social-Structural Factors - (10/16/23)
Integrating Long-Acting Injectable Cabotegravir for PrEP Into Standard of Care for Cisgender Women, Transgender Women, Transgender Men, and Men Who Have Sex With Men: Results From the PILLAR & EBONI Studies - (10/16/23)
Engaging Black Women on Cabotegravir LA for PrEP by Optimizing Novel Implementation Strategies (EBONI) Study: Provider Perceptions of Appropriateness of Cabotegravir LA for PrEP for Cis-and-Trans Black Women - (10/16/23)
Healthcare Staff Perceptions of Feasibility and Acceptability on Implementing Injectable HIV Pre-exposure Prophylaxis Into Standard of Care: Baseline Results From the PrEP Implementation Study for Cabotegravir Long Acting for Men in the Real World (PILLAR) - (10/16/23)
Acceptability of an HIV Pre-Exposure Prophylaxis (PrEP) Shared Decision-Making Tool (SDT) for Diverse Populations and Healthcare Providers - (10/13/23)

Helpful Tools
Finding The Best At Home Std Test
AAHIVM Routine Testing Coding Guide
The AAHIVM Coding Guide to Routine HIV Testing
Dentists' Willingness to Provide Expanded HIV Screening in Oral Health Care Settings: Results From a Nationally Representative Survey
Am J Public Health. 2014 Mar 13
Caring for Veterans with HIV
Linkage to Care: Linking newly diagnosed HIV-infected persons to Medical Providers through Linkage to Care Case Management (LTC)
State HIV Testing Laws
How to Apply for a Clinical Laboratory Improvement Amendments (CLIA) Certificate of Waiver
Rapid HIV Testing - CDC
Evaluation of a Rapid HIV Testing Initiative in an Urban, Hospital-Based Dental Clinic
HIV Rapid Test OraQuick Advance HIV1/2 Protocol
Coding Guidelines for Routine HIV Testing in Health Care Settings (courtesy of AAHIVM)
Clinical Laboratory Improvement Admentments (CLIA) Application for Certificate
OraQuick ADVANCE® HIV-1/2 Test Result Panel Training
News Updates

HIV prevention bill signed into law at state capitol

KGET News | February 8, 2024

Factors Associated With HIV Testing in Adolescent and Young Adult Females With a History of STI

Sage Journals | January 23, 2024

Ensuring pediatric index testing services are safe and ethical | January 21, 2024

Get Four Free At-?Home COVID-?19 Tests This Fall | January 20, 2024

Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study...

Lancet Glob Health. 2024 Feb;12(2):e243-e256. doi: 10.1016/S2214-109X(23)00536-3.

Rising Out-of-Pocket Costs for PrEP to Prevent HIV

POZ Magazine | January 12, 2024

Biomedical STI Prevention Evidence Is Inadequate for Cisgender Women | January 10, 2024

HIV Prevention: PrEP With TAF/FTC Is More Protective Than Placebo 

Infectious Disease Advisor | January 3, 2024

Researchers Study Strategies to Increase HIV Testing, Prevention via the Emergency Department

Children's Hospital of Philadelphia | December 5, 2023

How do I know if I have HIV?

aidsmap | December 2023

Making the most of a fertile PrEP landscape

The Lancet | December 2023

PrEP use, HIV testing increased among transgender people from 2014 to 2021

Healio | December 18, 2023

A vaginal ring that discreetly delivers anti-HIV drugs will reach more women

NPR | December 8, 2023

Removing Barriers That Limit Young Men at Risk for HIV Will Improve Access to PrEP 

Pharmacy Times | December 5, 2023

PrEP: Preventative HIV drug highly effective, study says

BBC | December 1, 2023

HIV epidemiology, prevention, treatment, and implementation strategies for public health

The Lancet | November 30, 2023

NATAP dedicated COVID website section

National AIDS Treatment Advocacy Project

Pre-exposure prophylaxis (PrEP) use history in people with antiretroviral resistance at HIV diagnosis: Findings from New York City HIV...

Oxford Academic | November 17, 2023

Bc Centre For Excellence In Hiv/Aids Launches New Initiative Targeting Sexually Transmitted Infections in BC

Yahoo Finance | November 17, 2023

Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection...

The Lancet | November 9, 2023

Science Update: Generic Daily HIV Prevention Pill for Young Men Who Have Sex with Men ... | November 6, 2023

No Longer a Death Sentence, HIV Diagnosis Still Hits Hard

Medscape | November 6, 2023

HIV/AIDS: Meeting Unmet Needs in Treatment and Prevention

United Nations | November 6, 2023

HRSA EHE PrEP data from community health centers (excel)

HIV+HEP Policy Institute | October 19, 2023

More than a third of eligible beneficiaries on PrEP for HIV, but disparities persist

The Hill | October 17, 2023

PrEP, a Key HIV Prevention Tool, Isn’t Reaching Black Women

KFF Health news | October 12, 2023

Missed Chances for Screening in Persons Newly Diagnosed with HIV: New York City, 2018–2022

NEJM | September 26, 2023

HIV Testing Post-Pandemic: Implications to Ending the HIV Epidemic Plan 

Infectious Disease Special Edition | September 1, 2023

Perspectives on long-acting formulations of pre-exposure prophylaxis (PrEP) among men who have sex with men who are non-adherent to daily oral...

BMC Public Health. 2023 Aug 28;23(1):1643. doi: 10.1186/s12889-023-16382-4

PrEParing for the End of the HIV Epidemic—A Public Health Imperative | Guidelines 

JAMA Network | August 22, 2023

Is Higher Adherence Required for Women using Oral Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Preexposure...

Clin Infect Dis. 2023 Aug 17;ciad485. doi: 10.1093/cid/ciad485

Pre-Exposure Prophylaxis Continues to be Effective in Preventing HIV, Certain Populations ... 

Pharmacy Times | August 9, 2023

Preparing for long-acting PrEP delivery: building on lessons from oral PrEP 

J Int AIDS Soc. 2023 Jul;26 Suppl 2:e26103. doi: 10.1002/jia2.26103.

Who prefers what? Correlates of preferences for next-generation HIV prevention products among a national U.S. sample of young men who...

J Int AIDS Soc. 2023 Jul;26 Suppl 2(Suppl 2):e26096. doi: 10.1002/jia2.26096.

PrEP Implant That Protects Against HIV Could Be Near | June 29, 2023

Disparities in HIV Prevention: New Data Reveal Racial and Regional Gaps in PrEP Usage 

Contagion Live | June 28, 2023

Urging the CDC to Recommend HIV Testing for People 65 and Older

POZ Magazine | June 20, 2023

Dried blood spot test can detect HIV and hepatitis, researchers say

Healio | April 24, 2023

PrEP for women in Europe: a systematic literature review

HIV Med. 2023 Apr 23. doi: 10.1111/hiv.13458

DoD Rolls Out Updated HIV PrEP Information | April 5, 2023

Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States...

J Int AIDS Soc. 2023 Mar;26(3):e26077. doi: 10.1002/jia2.26077.

Understanding Retention in the HIV Pre-Exposure Prophylaxis Cascade Among Cisgender Women - PubMed (

AIDS Patient Care STDS. 2023 Mar 24. doi: 10.1089/apc.2023.0009

Study examines parental concerns of their sexual and gender minority adolescents using PrEP 

News Medical | March 2, 2023

CDC-UNC Collaboration Yields Potential Long-term HIV Protection

UNC Health and UNC School of Medicine | February 9, 2023

Agents of change: Long-acting formulations for prevention and treatment of HIV 

MSF Access Campaign | February 2, 2023

Study Suggests Side-Effects and Costs Are Biggest Concerns for Users of HIV Pre-Exposure ... 

Newswise | January 31, 2023

Inconsistent Implementation Of The ACA’s Preventive Services Coverage Requirement Has Resulted In Differential, Unfavorable Coverage For PrEP

Health Affairs | January 26, 2023

Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir ... 

The Lancet | January 17, 2023

Long-acting PrEP injections could help reduce new cases of HIV in United States 

Imperial College London | January 17, 2023

New York Insurance Companies Now Required to Cover PrEP | December 25, 2022

HIV/AIDS Organizations Call on U.S. Government to Fund a National PrEP Program 

TheBody | December 20, 2022

Long-Acting Injectable PrEP as HIV Prevention Scores an A Grade

POZ | December 13, 2022

PrEP Far More Effective Than Sexual Abstinence In HIV Prevention: HIV Groups

CodeBlue - Galen Centre | December 7, 2022

COVID-19 Disrupted HIV Testing and Prevention

POZ | December 5, 2022

Acceptability and usability of oral fluid-based HIV self-testing among female sex workers and men who have sex with men in Morocco

BMC Public Health - BioMed Central | December 5, 2022

COVID-19 disruptions in HIV testing and prevention highlight need for innovation and investment before the next public health emergency

CDC | December 1, 2022

Preferences Across Pre-Exposure Prophylaxis Modalities Among Young Men Who Have Sex with Men in the United States: A Latent Class Analysis Study

AIDS Patient Care and STDsVol. 36, No. 11Behavioral and Psychosocial Research

Prison program for HIV PrEP enrolls 93% of eligible people

Healio | November 11, 2022

Presenting a Range of HIV PrEP Options Encourages Uptake

Contagion Live | November 2, 2022

High PrEP Awareness in US Women, But Only 20% Ever Used It

IDWeek 2022, October 19-23, 2022, Washington, DC | Courtesy of NATAP

PrEP Interest and Preferences Among US Black and Hispanic Men – A 2021 National Survey

IDWeek 2022; October 19-23, 2022; Virtual and Washington, DC | Courtesy of NATAP

Perceived influence of alcohol consumption, substance use, and mental health on PrEP adherence and condom use among PrEP-prescribed gay, bisexual, and other men-who-have-sex-with-men: a qualitative investigation 

BMC Public Health. 2022 Oct 7;22(1):1875. doi: 10.1186/s12889-022-14279-2.

Increased HIV Infection Linked to Pandemic-Related Access to PrEP

Medscape | October 6, 2022

Perceived Barriers to and Facilitators of Long-Acting Injectable HIV PrEP Use Among Black, Hispanic/Latino, and White Gay, Bisexual, and Other Men Who Have Sex With Men 

AIDS Educ Prev. 2022 Oct;34(5):365-378. doi: 10.1521/aeap.2022.34.5.365.

Projected Impact of Expanded Long-Acting Injectable PrEP Use Among Men Who Have Sex With Men on Local HIV Epidemics | October 6, 2022

Zero knowledge and high interest in the use of long-acting injectable pre-exposure prophylaxis (PrEP) among adolescent men who have sex with men and transgender women in two capital cities in Brazil 

BMC Public Health. 2022 Sep 12;22(1):1728. doi: 10.1186/s12889-022-14134-4.

White House Publishes Federal Implementation Plan for National HIV/AIDS Strategy | August 26, 2022

Injectable PrEP is safe and effective in preventing HIV/AIDS among trans women, study finds 

Xtra Magazine | August 19, 2022

New data shows inequities in use of medicine that prevents HIV 

Atlanta Journal-Constitution | August 15, 2022

HIV Testing Dropped Among Children, Adolescents During Early COVID-19 

American Journal of Managed Care | July 20, 2022

Lawyer Who Fought Abortion Rights Takes Aim at HIV Prevention PrEP

POZ Magazine | july 15, 2022

On-Demand PrEP Works as Well as Daily Pills

POZ | July 12, 2022

Walgreens helps lead largest coordinated HIV testing event in US 

Walgreens Newsroom | July 1, 2022


  2019 Archives 2020 Archives 2021 Archives 2022 Archives